.
Proudly Canadian, Globally Trusted
With roots in Quebec, Canada, we take pride in delivering uncompromising scientific integrity and reliability. Serving pharmaceutical, biotech, and medical device companies in both Canada and the U.S., our Canadian values of precision and trust define every partnership.
A North American Company with Global Impact
Operating proudly from Canada and extending across the U.S., we provide analytical testing and R&D services that meet the highest international regulatory expectations. Our expertise ensures confidence in global pharmaceutical and healthcare markets.
GMP Compliant. Health Canada Licensed.
ResolveMass Laboratories now holds a Health Canada Drug Establishment Licence — extending our services beyond R&D drug development. We now take on full GMP projects, from analytical testing to regulatory-ready release.
Health Canada — GMP Compliant
Drug Establishment Licence 3-002945-A
FDA-Registered Laboratory
Establishment Identifier 3042696771
ISO 9001:2015 Certified
Quality Management System
Expanded Capability
Your pipeline no longer stops at R&D. Neither do we.
The same scientists who resolve your hardest development challenges now carry your molecule through GMP — one lab, one quality system, zero handoffs.
Established Expertise
R&D Drug Development
The specialized CRO capability our clients across North America rely on — built for complex molecules.
- Custom organic & polymer synthesis
- Formulation & analytical method development
- Mass spectrometry — bioanalytical, nitrosamine, PFAS, E&L
- Peptide & polymer characterization
SERVING PHARMA & BIOTECH ACROSS NORTH AMERICA
Now Accepting NEW
GMP Projects
With our Health Canada Drug Establishment Licence, we now execute projects under full GMP compliance.
- GMP analytical testing & release support
- Regulatory-ready documentation & data integrity
- Health Canada & FDA-aligned quality systems
- Seamless transfer from your R&D program
LICENCE 3-002945-A · GMP COMPLIANT
Our Products and Services
Quality & Regulatory Compliance
We are GMP Compliant under Health Canada
Drug Establishment Licence Number:
3-002945-A
We are United States FDA-registered laboratory, reinforcing our commitment to regulatory compliance, data integrity, and global pharmaceutical standards.
FDA Establishment Identifier No.: 3042696771
We are also ISO 9001:2015 certified for our Quality Management System (QMS).
📄 Download our ISO 9001:2015 Certificate:
👉 Click here to download the certificate (PDF)
Trusted by Leading Pharmaceutical and Biotech Companies
Corporate Introductory Video
.
Our Story
ResolveMass Laboratories Inc. is a renowned contract research organization specializing in polymer synthesis and analytical services for drug delivery and matrices.
Custom Synthesis CRO
Tailored organic synthesis projects by our skilled Ph.D. scientists for precise outcomes.
Advanced Analytical Services
Unraveling the structural complexities of polymer compounds through cutting-edge instruments.
Expert Polymer Synthesis
Decades of experience in crafting specialized polymers for medical devices and pharmaceutical formulations.
Learn with us
Peptide Drug Substance vs. Drug Product Characterization: Analytical Differences and Regulatory Requirements
Introduction The key distinction in Peptide Drug Substance vs. Drug Product Characterization is rooted in...
How a Biosimilar CDMO in United States Supports Analytical Comparability and Regulatory Success
Introduction A Biosimilar CDMO in United States plays a critical role in achieving analytical comparability...
Biosimilar CDMO in Canada: From Cell Line Development to Commercial Manufacturing
Introduction Partnering with a specialized biosimilar CDMO in Canada allows biopharmaceutical companies to address the...
Case Study: Analytical Characterization of Dexamethasone Injection
Introduction: Analytical Characterization of Dexamethasone Injection is one of the most important activities in developing...
Why Biotech Companies Partner with a Peptide CDMO in United States for Drug Development
Introduction Biotechnology companies increasingly collaborate with a Peptide CDMO in United states to establish dependable...
Peptide CDMO in Canada: Complete Guide to Peptide Development, Manufacturing, and Analytical Testing
Introduction A Peptide CDMO in Canada offers the specialized synthetic chemistry expertise, cGMP-compliant manufacturing capabilities,...
Unique Value Proposition
ResolveMass Laboratories Inc.: Comprehensive Scientific Expertise You Can Rely On
ResolveMass Laboratories Inc. is a trusted Canadian contract research organization offering a wide spectrum of specialized services spanning polymer synthesis, advanced analytical testing, and custom organic synthesis. With over a decade of experience supporting pharmaceutical, biotech, and industrial clients, we bring scientific precision and regulatory insight to every project. Our core capabilities include Polymer Synthesis and Characterization, Peptide Characterization, Organic Synthesis, Nitrosamine Testing and Analysis, PFAS Testing, and Extractable & Leachable Studies, as well as a broad suite of analytical techniques such as HPLC, GC-MS, MALDI-TOF, NMR, and FTIR.
Our multidisciplinary team includes chemists, analytical scientists, and regulatory experts with advanced academic and industry backgrounds. We excel at developing customized, high-quality solutions—whether you need innovative polymer designs, impurity profiling, or confirmatory testing that meets global regulatory standards.
Clients across North America choose ResolveMass Laboratories for our deep technical knowledge, commitment to quality, and ability to deliver reproducible, reliable data that drives confident decision-making. When precision, innovation, and trust matter—ResolveMass is your partner of choice.